Table 5.
Total score | N (total = 1250) | Median survival, years (95% CI) | Five-year survival rate (%) |
---|---|---|---|
32 | 6 | 0.48 (0.10, 1.71) | 0.0 |
33 | 4 | 0.82 (0.60, 1.61) | 0.0 |
34 | 4 | 0.76 (0.08, 5.49) | 25.0 |
35 | 7 | 0.36 (0.06, 0.94) | 0.0 |
36 | 9 | 0.39 (0.05, 1.78) | 0.0 |
37 | 14 | 0.89 (0.15, NA) | 0.0 |
38 | 11 | 0.82 (0.38, 6.57) | 24.2 |
39 | 41 | 1.68 (1.0, 2.78) | 26.8 |
40 | 19 | 1.51 (0.47, 2.57) | 7.7 |
41 | 59 | 1.31 (1.08, 2.0) | 16.4 |
42 | 43 | 2.95 (1.79, 4.67) | 27.2 |
43 | 61 | 3.04 (1.56, 4.29) | 16.8 |
44 | 69 | 3.45 (2.07, 5.30) | 38.8 |
45 | 81 | 4.77 (2.85, NA) | 49.0 |
46 | 157 | 5.26 (4.30, 6.63) | 52.0 |
47 | 52 | 4.31 (3.70, NA) | 48.5 |
48 | 250 | NA (7.73, NA) | 72.4 |
49 | 24 | NA (3.68, NA) | 69.1 |
50 | 224 | NA (NA, NA) | 80.3 |
51 | – | – | – |
52 | 115 | NA (NA, NA) | 94.1 |
Variables used: Quality of Life, Age, Sex, Eastern Cooperative Oncology Group performance status (PS), Smoking Cessation, Tumor Size, Regional Nodal Involvement, Distant Metastasis.